Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of Seloxavir Marboxil and Oseltamivir in Healthy Adults
NCT06057103Phase 1Completed
- Sponsor
- Zenshine Pharmaceuticals Co., Ltd.
- Start
- Aug 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Seloxavir marboxil in influenza, sponsored by Zenshine Pharmaceuticals Co., Ltd. Primary endpoint: Pharmacokinetic parameters of active metabolite ZX-7101 at Day 20. Started Aug 2023; status: completed.
02
Drugs
Seloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT06057103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06057103.